Health Canada approves Pfizer's gene therapy for treatment of hemophilia
Pfizer said on Wednesday that Canada's health regulator approved its gene therapy for the treatment of a rare inherited bleeding disorder called hemophilia B ahead of a U.S. decision.
Source: CBC | Health - Category: Consumer Health News Tags: News/Health Source Type: news
More News: Bleeding | Canada Health | Gene Therapy | Genetics | Haemophilia | Health | Hemophilia | Pfizer